Abstract
Tumor necrosis factor-alpha (TNF-α) plays a crucial role in the development of autoimmune diseases, and anti-TNF-α agents are used in the treatment of this group of diseases. However, some adverse events such as various autoimmune diseases can occur with use of these agents. In this report, we present a female case who was diagnosed as bullous pemphigoid while receiving adalimumab for rheumatoid arthritis. (Turk J Rheumatol 2010; 25: 214-6)
Similar Articles
Article Info
Published In
Journal
Archives of Rheumatology
Volume / Issue
Volume 25 · Issue 4 · December 2010
Pages
214-216
History
Published Online
December 31, 2010
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Affiliations
1
Özlem Altındağ
Gaziantep Üniversitesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Gaziantep, Turkey
2
Ali Aydeniz
Gaziantep Üniversitesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Gaziantep, Turkey
3
Savaş Gürsoy
Gaziantep Üniversitesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Gaziantep, Turkey
Cite this Article
Özlem Altındağ, Ali Aydeniz, & Savaş Gürsoy. (2010). A Case with Anti TNF- α Induced Bullous Pemhigoid. Archives of Rheumatology, 25(4), 214–216. https://doi.org/10.5152/tjr.2010.31
Outlines